Literature DB >> 24522018

Expression of genes encoding cytokines and corticotropin releasing factor are altered by citalopram in the hypothalamus of post-stroke depression rats.

Shan-Shan Wang1, Ya-Guang Wang2, Hai-Ying Chen3, Zhi-Ping Wu3, Heng-Ge Xie1.   

Abstract

OBJECTIVES: To establish a rat model of post-stroke depression (PSD), and examine expression of genes encoding corticotropin releasing factor (CRF), interleukin 1 beta (IL-1β), and tumor necrosis factor alpha (TNF-α) in the hypothalamus of PSD rats.
METHODS: Rats were subjected to middle cerebral artery occlusion (MCAO) and chronic mild unpredictable stress (CUMS). Open field test and sucrose preference were used to examine depressive-like behaviors. Observed changes in gene expression levels in the hypothalamus of PSD rats were evaluated.
RESULTS: MCAO with CUMS resulted in reduction of sucrose preference and locomotor activity. Genes encoding TNF-α, IL-1β and CRF were highly expressed in the hypothalamus of rats subjected to MCAO and CUMS. The antidepressant citalopram, a selective serotonin reuptake inhibitor, had inhibitory effects on the expression of the aforementioned genes. We observed a correlation between CRF and IL-1β mRNA levels in the citalopram-treated group of rats.
CONCLUSION: The etiology of PSD is associated with cytokine expression in the hypothalamus and with hypothalamic-pituitary-adrenal axis activity. Citalopram administration inhibited the expression of TNF-α and IL-1β transcripts in the hypothalamus, suggesting that selective serotonin reuptake inhibitors may be appropriate for PSD therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24522018

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  5 in total

Review 1.  Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke.

Authors:  Aldo Bonaventura; Luca Liberale; Alessandra Vecchié; Matteo Casula; Federico Carbone; Franco Dallegri; Fabrizio Montecucco
Journal:  Int J Mol Sci       Date:  2016-11-25       Impact factor: 5.923

2.  Shuyu capsules relieve liver-qi depression by regulating ERK-CREB-BDNF signal pathway in central nervous system of rat.

Authors:  Hongyan Wang; Yingquan Zhang; Helou Li; Wei Zeng; Mingqi Qiao
Journal:  Exp Ther Med       Date:  2017-09-18       Impact factor: 2.447

3.  Comprehensive Landscape of Immune Infiltration and Aberrant Pathway Activation in Ischemic Stroke.

Authors:  Rongrong Liu; Pingping Song; Xunhu Gu; Weidong Liang; Wei Sun; Qian Hua; Yusheng Zhang; Zhengang Qiu
Journal:  Front Immunol       Date:  2022-01-24       Impact factor: 7.561

Review 4.  Shugan Jieyu Capsule in Post-Stroke Depression Treatment: From Molecules to Systems.

Authors:  Meng Zhang; Xue Bai
Journal:  Front Pharmacol       Date:  2022-01-24       Impact factor: 5.810

5.  Does citalopram effectively treat post-stroke depression?: A protocol for systematic review and meta analysis.

Authors:  Jing Hu; Li Ma; Zeng-Ye Yang
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.